Paris Diderot University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Paris France (1971)

Organization Overview

First Clinical Trial
1998
NCT00005584
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AP-HP and Paris VII University | AP-HP and Paris XII University | AP-HP and University of Paris VII | centre de recherche bioclinique -Hopital st louis | Hopital Saint Louis France | Hopital Saint-Louis, France | HOPITAL SAINT LOUIS - LA ROCHELLE | Hopital Saint-Louis, Paris | HOPITAL SAINT LOUIS - PARIS CEDEX 10 | Hopital Saint Louis Paris service des Maladies infectieuses et Tropicales | Hôpital Saint Louis - Service hématologie-greffe | Hopital Saint-Louis, Service hematologie Senior | Hôpital Saint Louis - Service hématologie séniors | Hôpital Saint Louis / Université Paris Diderot | Hopital St Louis - Paris - France | HOPITAL ST LOUIS/SCE DERMATOLOGIE/1 AV. CLAUDE VELLEFAUX (Paris- France) | Hospital Saint Louis Paris | INSERM, ECEVE UMR 1123, Paris | Pneumology Department, Hopital Saint Louis | St. Louis Hospital, Haematology Division, Paris | U717 INSERM universite Paris7, Hopital Saint-Louis, Paris, France

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Aplastic (Phase 3)

Bronchiolitis (Phase 2)

Bronchiolitis Obliterans (Phase 2)

Esophageal Neoplasms (Phase 2)

HIV Infections (Phase 2)

Influenza, Human (Phase 3)

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lymphoma (Phase 3)

Multiple Myeloma (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Viral (Phase 3)

Preleukemia (Phase 2)

Psoriasis (Phase 3)

Urticaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 38